2m 2m 2m 2m 2m 2m 2m
Bsch+Lb (BLCO)
NYSE
$15.10-$0.14 (-0.95%)
Price as of Jun 23, 2026 6:49 PM EDT- $5.3BMarket Cap
- 24.42%1-Year Change
- Medical Instruments & SuppliesIndustry
Bsch+Lb (BLCO)
$15.10-$0.14 (-0.95%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 5.1B +6.03% | 4.8B +15.56% | 4.1B +10.03% | 3.8B N/A | |
Cost of Revenue | 2.0B -45.38% | 3.7B +128.01% | 1.6B +8.10% | 1.5B N/A | |
Gross Profit | 3.0B +189.88% | 1.0B -58.19% | 2.5B +11.34% | 2.2B N/A | |
Sales and Marketing Expense | 2.2B +7.30% | 2.1B +19.93% | 1.7B +17.46% | 1.5B N/A | |
Research and Development Expense | -371.0M +8.16% | -343.0M +5.86% | -324.0M +5.54% | -307.0M N/A | |
Depreciation and Amortization Expense | 421.0M -3.44% | 436.0M +14.14% | 382.0M +0.79% | 379.0M N/A | |
Total Operating Expenses | 5.0B +7.76% | 4.6B +15.26% | 4.0B +12.78% | 3.6B N/A | |
Operating Profit | 113.0M -30.25% | 162.0M +24.62% | 130.0M -37.20% | 207.0M N/A | |
Interest Income | 12.0M -20.00% | 15.0M 0.00% | 15.0M +150.00% | 6.0M N/A | |
Interest Expense | -421.0M +5.51% | -399.0M +40.99% | -283.0M +93.84% | -146.0M N/A | |
Interest Income and Expense and Net | -409.0M +6.51% | -384.0M +43.28% | -268.0M +91.43% | -140.0M N/A | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | -74.0M +469.23% | -13.0M N/A | |
Income before Taxes | -317.0M +35.47% | -234.0M +40.96% | -166.0M -327.40% | 73.0M N/A | |
Income Taxes | 35.0M -50.70% | 71.0M -13.41% | 82.0M +41.38% | 58.0M N/A | |
Extraordinary Items | 0 -100.00% | 5.0M N/A | 0 -100.00% | 1.0M N/A | |
Net Income | -360.0M +13.56% | -317.0M +21.92% | -260.0M -4,433.33% | 6.0M N/A | |
Net Income from Continuing Operations Applicable to Common | -317.0M +35.47% | -234.0M +40.96% | -166.0M -327.40% | 73.0M N/A | |
Basic EPS and Net Income | -1.02 +13.33% | -0.90 +21.62% | -0.74 -3,800.00% | 0.02 N/A | |
Diluted EPS and Net Income | -1.02 +13.33% | -0.90 +21.62% | -0.74 -3,800.00% | 0.02 N/A | |
Basic Weighted Average Shares | 353.8M +0.57% | 351.8M +0.37% | 350.5M +0.14% | 350.0M N/A | |
Diluted Weighted Average Shares | 353.8M +0.57% | 351.8M +0.37% | 350.5M +0.14% | 350.0M N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 383.0M +25.57% | 305.0M -7.85% | 331.0M -6.50% | 354.0M N/A | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 383.0M +25.57% | 305.0M -7.85% | 331.0M -6.50% | 354.0M N/A | |
Total Current Assets | 3.0B +6.78% | 2.8B +1.68% | 2.7B +28.31% | 2.1B N/A | |
Accumulated Depreciation | 1.9B +12.59% | 1.7B +3.31% | 1.6B +7.59% | 1.5B N/A | |
Property and Plant and Equipment and Net | 1.8B +18.65% | 1.5B +6.83% | 1.4B +6.92% | 1.3B N/A | |
Total Long-Term Assets | 310.0M +5.44% | 294.0M +30.67% | 225.0M +4.65% | 215.0M N/A | |
Total Assets | 14.0B +4.11% | 13.5B +0.20% | 13.4B +20.62% | 11.1B N/A | |
Income Taxes Payable | 19.0M +46.15% | 13.0M -7.14% | 14.0M +100.00% | 7.0M N/A | |
Total Short-Term Debt | 28.0M -30.00% | 40.0M +33.33% | 30.0M +20.00% | 25.0M N/A | |
Total Current Liabilities | 1.9B +10.47% | 1.7B +10.07% | 1.6B +21.84% | 1.3B N/A | |
Total Long-Term Debt | 5.0B +5.82% | 4.7B +4.68% | 4.5B +87.97% | 2.4B N/A | |
Total Long-Term Liabilities | 521.0M +21.16% | 430.0M +8.31% | 397.0M +20.67% | 329.0M N/A | |
Total Liabilities | 7.5B +8.35% | 6.9B +6.18% | 6.5B +61.32% | 4.0B N/A | |
Retained Earnings | -931.0M +63.05% | -571.0M +124.80% | -254.0M -4,333.33% | 6.0M N/A | |
Total Stockholders Equity | 6.4B -0.39% | 6.5B -5.50% | 6.8B -2.60% | 7.0B N/A | |
Total Shares Outstanding | 310.4M -11.90% | 352.4M +0.42% | 350.9M +0.26% | 350.0M N/A | |
Cash Flow | |||||
Cash from Operating Activities | 283.0M +21.98% | 232.0M +1,464.71% | -17.0M -104.93% | 345.0M N/A | |
Capital Expenditures | 349.0M +19.93% | 291.0M +60.77% | 181.0M +3.43% | 175.0M N/A | |
Cash from Investing Activities | -455.0M +10.44% | -412.0M -80.46% | -2.1B +880.93% | -215.0M N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 225.0M +26.40% | 178.0M -91.43% | 2.1B +2,465.43% | 81.0M N/A | |
Financials Ratio | |||||
Gross Margin | 59.74% +173.38% | 21.85% -63.82% | 60.40% N/A | N/A N/A | |
Operating Margin | 2.22% -34.21% | 3.38% +7.84% | 3.14% N/A | N/A N/A | |
Return on Assets | -2.62% +11.17% | -2.36% +11.39% | -2.11% N/A | N/A N/A | |
Return on Equity | -5.57% +17.10% | -4.76% +27.05% | -3.75% N/A | N/A N/A | |
Revenue Growth | 6.03% -61.23% | 15.56% +55.08% | 10.03% N/A | N/A N/A | |
Current Ratio | 1.55 -3.34% | 1.60 -7.62% | 1.74 N/A | N/A N/A | |
Cash Ratio | 0.20 +13.68% | 0.18 -16.27% | 0.21 N/A | N/A N/A | |
Debt-to-Equity Ratio | 0.78 +5.93% | 0.74 +10.98% | 0.67 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.36 +1.35% | 0.36 +4.66% | 0.34 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow